Other
Symptomatic therapy
Symptomatic therapy is an intervention with 4 clinical trials. Currently 1 active trials ongoing.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
1(25%)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Other(3)
Detailed Status
unknown3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 4
Trials by Phase
Phase 41 (33.3%)
N/A2 (66.7%)
Trials by Status
recruiting125%
unknown375%
Recent Activity
1 active trials
Showing 4 of 4
recruitingnot_applicable
Tick-borne Encephalitis and Borrelial Antibodies in Serum
NCT03956446
unknownphase_4
Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children
NCT04996485
unknownnot_applicable
Tick-borne Encephalitis and Positive Borrelial Antibodies
NCT02463942
unknown
Aseptic Meningoencephalitis in Slovenia
NCT02328469
Clinical Trials (4)
Showing 4 of 4 trials
NCT03956446Not Applicable
Tick-borne Encephalitis and Borrelial Antibodies in Serum
NCT04996485Phase 4
Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children
NCT02463942Not Applicable
Tick-borne Encephalitis and Positive Borrelial Antibodies
NCT02328469
Aseptic Meningoencephalitis in Slovenia
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4